Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

BRITISH JOURNAL OF DERMATOLOGY(2024)

引用 0|浏览7
暂无评分
关键词
upadacitinib,dupilumab,atopic dermatitis,moderate-to-severe,pruritus
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要